Premature mortality and disease burden attributable to major chronic diseases in Huangyan District， Taizhou City， Zhejiang Province， 2015‒2024
10.19428/j.cnki.sjpm.2025.250206
- VernacularTitle:2015—2024年浙江省台州市黄岩区重大慢性病过早死亡率及疾病负担分析
- Author:
Mei ZHENG
1
;
Panpan MOU
1
;
Youping SHU
1
;
Meng WANG
2
Author Information
1. Huangyan Center for Disease Control and Prevention, Taizhou, Zhejiang 318020, China
2. Institute for Noncommunicable Chronic Disease Control and Prevention, Zhengjiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China
- Publication Type:Journal Article
- Keywords:
major chronic diseases;
premature mortality rate;
crude mortality rate;
standardized mortality rate;
potential life loss
- From:
Shanghai Journal of Preventive Medicine
2025;37(12):985-991
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo analyze the premature mortality and disease burden attributable to major chronic diseases in Huangyan District, Taizhou City, Zhejiang Province from 2015 to 2024, and to provide data support for the efforts of local chronic disease prevention and control. MethodsBased on the mortality surveillance data of registered residents in Huangyan District from 2015 to 2024, mortality rates and premature mortality rates of malignant tumors, diabetes mellitus, cardiovascular and cerebrovascular diseases, and chronic respiratory diseases were calculated. Indicators such as potential years of life lost (PYLL), average years of life lost (AYLL), and potential years of life lost rate (PYLLR) were also estimated. ResultsFrom 2015 to 2024, the crude mortality rate of major chronic diseases among registered residents in Huangyan District was 514.27/100 000, with an age-standardized mortality rate of 377.17/100 000. The crude (standardized) mortality rate was 588.00/100 000 (422.00/100 000) in males and 440.50/100 000 (328.08 /100 000) in females, indicating higher mortality among males. The fluctuation ranges of premature mortality rate of malignant tumors, diabetes mellitus, cardiovascular and cerebrovascular diseases and chronic respiratory diseases were 4.53%‒8.38%, 0.15%‒0.72%, 2.00%‒4.03% and 0.23%‒0.47%, respectively. The premature mortality rates of malignant tumors and cardiovascular and cerebrovascular diseases showed a decreasing trend (all P<0.05), while that of diabetes mellitus increased statistically significant (P<0.05). Malignant tumors accounted for the highest PYLL and PYLLR (5 107.15 person-years and 9.47‰, respectively), whereas chronic respiratory diseases contributed the lowest (213.25 person-years and 0.40‰, respectively). Cardiovascular and cerebrovascular diseases resulted in the highest AYLL (10.62 years), while chronic respiratory diseases had the lowest (7.64 years). The PYLL, AYLL, and PYLLR for major chronic diseases were 5 432.20 person-years, 10.24 years, and 19.99‰ in males, and 2 617.15 person-years, 10.49 years, and 9.78‰ in females, respectively, indicating greater loss of life expectancy in males than in females. ConclusionFrom 2015 to 2024, both age-standardized mortality and premature mortality attributable to major chronic diseases of registered residents declined in Huangyan District, reflecting notable achievements in chronic disease control. However, malignant tumors and cardiovascular and cerebrovascular diseases remained the main causes of death, while the burden of diabetes mellitus continued to rise. Males experienced higher premature mortality rate and life expectancy loss caused by major chronic diseases than females. Targeted chronic disease screening, risk factor surveillance, and interventions among high-risk populations should be further strengthened by local health authorities.
